RecruitingNot ApplicableNCT07048496

Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support

Sponsor

University of Pennsylvania

Enrollment

50 participants

Start Date

Jul 5, 2025

Study Type

INTERVENTIONAL

Conditions

Bladder Cancer

Summary

The proposed project will have two separate cohorts. The first will be to perform a more in-depth qualitative assessment of the barriers and facilitators for treatment compliance for non-muscle invasive bladder cancer. The second arm will be to create and test a BCG at home program. Participants in the second cohort will be enrolled in a conversational agent to measure patient symptoms and quality of life and improve self-efficacy.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is exploring whether a bladder cancer treatment — normally done in a hospital — could be safely done at home. It focuses on BCG therapy, a liquid drug placed directly into the bladder through a small tube. Researchers are also gathering input from healthcare providers and patients to develop better support tools. **You may be eligible if (Group 1 — past patients or clinicians):** - You are 18 or older - You completed bladder cancer treatment within the past year, OR you are a healthcare professional with at least 2 years of experience giving BCG therapy **You may be eligible if (Group 2 — new patients):** - You are 18 or older - You have been diagnosed with early-stage bladder cancer and have been prescribed BCG as your initial treatment **You may NOT be eligible if:** - You cannot give informed consent - You cannot have a catheter placed (e.g., due to a narrowed urethra) - You have had a previous serious reaction to BCG - You do not have access to a mobile phone - You cannot read or respond to written English Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBCG delivery at home

The BCG at home project will be a single-arm prospective pilot, to evaluate the feasibility, scalability and effectiveness of home treatment, and utilize the BB-Bot (chatbot) for PRO and adverse event measurement.